Early research (Phase 1)Ended earlyNCT00100971What this trial is testingVaccine Therapy in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Boston Medical Center 9
Not applicableLooking for participantsNCT06891144What this trial is testingEpidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction TherapyWho this might be right forAML, Adult French Innovative Leukemia Organisation 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03603964What this trial is testingGuadecitabine Extension StudyWho this might be right forAcute Myeloid LeukemiaMyeloid Dysplastic Syndrome Astex Pharmaceuticals, Inc. 35
Early research (Phase 1)Not Yet RecruitingNCT06252584What this trial is testingMulti-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia PatientsWho this might be right forAcute Myeloid Leukemia, Adult University Hospital Tuebingen 20
Early research (Phase 1)Study completedNCT00270452What this trial is testingSafety of Peptide Vaccination for Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndrome (MDS) National Heart, Lung, and Blood Institute (NHLBI) 9
Early research (Phase 1)Looking for participantsNCT07107126What this trial is testingSafety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome Remedy Plan, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00004255What this trial is testingTreatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow TransplantationWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Chimeric Therapies
Early research (Phase 1)Study completedNCT01137747What this trial is testingCarfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Washington University School of Medicine 18
Testing effectiveness (Phase 2)Ended earlyNCT00555048What this trial is testingAlemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT04065399What this trial is testingRevumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Lineage Acute Leukemia+2 more Syndax Pharmaceuticals 447
Not applicableUnknownNCT03659084What this trial is testingStudy of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forMyeloid LeukemiaMyelodysplastic Syndromes Hospices Civils de Lyon 150
Not applicableNot Yet RecruitingNCT06758726What this trial is testingMitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AMLWho this might be right forAML Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT02461121What this trial is testingHLA-mismatched MST vs HLA-matched NST for AML in Intermediate-riskWho this might be right forAcute Myeloid Leukemia The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156
Testing effectiveness (Phase 2)Study completedNCT00241358What this trial is testingStudy Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological MalignanciesWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more Washington University School of Medicine 92
Not applicableLooking for participantsNCT01311258What this trial is testingMonitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome University of Rochester 400
Early research (Phase 1)Ended earlyNCT00887926What this trial is testingStudy of IMC-EB10 in Participant With LeukemiaWho this might be right forMyeloid Leukemia Eli Lilly and Company 25
Early research (Phase 1)Active Not RecruitingNCT05015426What this trial is testingGamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCTWho this might be right forAcute Myeloid Leukemia H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Ended earlyNCT01743807What this trial is testingPhase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous LeukemiaWho this might be right forRelapsed Acute Lymphoblastic LeukemiaRelapsed Acute Myelogenous Leukemia Therapeutic Advances in Childhood Leukemia Consortium 4
Early research (Phase 1)Study completedNCT00054236What this trial is testingCombination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Case Comprehensive Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT01749111What this trial is testingComparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD ProphylaxisWho this might be right forAcute Myelogenous LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disease+3 more Hospital Israelita Albert Einstein 3